BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18066095)

  • 1. Targeted cancer therapies based on the inhibition of DNA strand break repair.
    O'Connor MJ; Martin NM; Smith GC
    Oncogene; 2007 Dec; 26(56):7816-24. PubMed ID: 18066095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair.
    Bolderson E; Richard DJ; Zhou BB; Khanna KK
    Clin Cancer Res; 2009 Oct; 15(20):6314-20. PubMed ID: 19808869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New opportunities in chemosensitization and radiosensitization: modulating the DNA-damage response.
    Luo Y; Leverson JD
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):333-42. PubMed ID: 15877529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical poly(ADP-ribose) polymerase inhibitors for the treatment of cancer.
    Lewis C; Low JA
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1051-6. PubMed ID: 18058575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the DNA damage response in oncology: past, present and future perspectives.
    Basu B; Yap TA; Molife LR; de Bono JS
    Curr Opin Oncol; 2012 May; 24(3):316-24. PubMed ID: 22476188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kinases in cancer therapy.
    Ashwell S; Zabludoff S
    Clin Cancer Res; 2008 Jul; 14(13):4032-7. PubMed ID: 18593978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting poly(ADP-ribose) polymerase: a two-armed strategy for cancer therapy.
    Plummer ER; Calvert H
    Clin Cancer Res; 2007 Nov; 13(21):6252-6. PubMed ID: 17975135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
    Kinsella TJ
    Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA structure and integrity checkpoints during the cell cycle and their role in drug targeting and sensitivity of tumor cells to anticancer treatment.
    Skladanowski A; Bozko P; Sabisz M
    Chem Rev; 2009 Jul; 109(7):2951-73. PubMed ID: 19522503
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA repair pathways and their implication in cancer treatment.
    Pallis AG; Karamouzis MV
    Cancer Metastasis Rev; 2010 Dec; 29(4):677-85. PubMed ID: 20821251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting DNA repair as a promising approach in cancer therapy.
    Damia G; D'Incalci M
    Eur J Cancer; 2007 Aug; 43(12):1791-801. PubMed ID: 17588740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical strategies for development of ATR inhibitors.
    Llona-Minguez S; Höglund A; Jacques SA; Koolmeister T; Helleday T
    Expert Rev Mol Med; 2014 May; 16():e10. PubMed ID: 24810715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twists and turns in the function of DNA damage signaling and repair proteins by post-translational modifications.
    Déry U; Masson JY
    DNA Repair (Amst); 2007 May; 6(5):561-77. PubMed ID: 17258515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting DNA repair mechanisms in cancer.
    Furgason JM; Bahassi el M
    Pharmacol Ther; 2013 Mar; 137(3):298-308. PubMed ID: 23107892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage and repair in translational oncology: an overview.
    Reed E
    Clin Cancer Res; 2010 Sep; 16(18):4511-6. PubMed ID: 20823144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspective on the pipeline of drugs being developed with modulation of DNA damage as a target.
    Plummer R
    Clin Cancer Res; 2010 Sep; 16(18):4527-31. PubMed ID: 20823148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging cancer therapeutic opportunities target DNA-repair systems.
    Ding J; Miao ZH; Meng LH; Geng MY
    Trends Pharmacol Sci; 2006 Jun; 27(6):338-44. PubMed ID: 16697054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of Cancer.
    Velic D; Couturier AM; Ferreira MT; Rodrigue A; Poirier GG; Fleury F; Masson JY
    Biomolecules; 2015 Nov; 5(4):3204-59. PubMed ID: 26610585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology in cancer therapy: targeting the inhibition of key DNA repair pathways.
    Aziz K; Nowsheen S; Georgakilas AG
    Curr Mol Med; 2010 Oct; 10(7):626-39. PubMed ID: 20712589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA topoisomerases in cancer chemotherapy: basic and applied aspects.
    Cortés F; Pastor N
    Cytobios; 2001; 106 Suppl 2():217-27. PubMed ID: 11545448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.